Loss of α-smooth muscle actin immunostaining is not a useful marker for functional impairment: a comparison from patients with and without small bowel motility disorder
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf033 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Katrina Collins und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, United States. Hauptthemen laut MEDLINE: Actins, Muscle, Smooth, Jejunum. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Objective
Prior studies have reported the loss of α-smooth muscle actin (α-SMA) immunoreactivity in the inner circular layer of the muscularis propria in small bowel motility disorder cases, but this remains controversial with conflicting data. In this study, we aimed to characterize α-SMA immunoreactivity in the muscularis propria of the small intestine—specifically, jejunum—in patients with and without small bowel motility disorder.
Methods
A total of 28 transmural proximal jejunum biopsy specimens from adult patients with clinical impression of upper gastrointestinal dysmotility disorder and 64 control tissues were evaluated. The controls were full-thickness, longitudinal tissue sections from segmental resections performed due to gunshot wounds, multivisceral transplant donation, and tumors. Immunostaining for α-SMA was performed with appropriate controls to confirm the presence of immunoreactivity in the circular and longitudinal muscle layers of the muscularis propria in each sample and recorded as retained or diminished.
Results
In the small bowel motility disorder and control cases, 42.9% (12/28) and 70.3% (49/64) of the cases showed no or minimal α-SMA immunoreactivity in the inner circular layer with peripheral accentuation, respectively.
Conclusions
Loss or diminished α-SMA immunoreactivity in the inner circular layer of the muscularis propria occurs with a similar frequency in cases with and without small bowel motility disorder and does not correlate with impairment of function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, United States.
- Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, United States.
ORCID-Profile: Iván A González
Zitieren
APA
Collins, K., González, I. A., Idrees, M. T., Gupta, A., Wo, J. M., & Saeed, O. A. M. (2025). Loss of α-smooth muscle actin immunostaining is not a useful marker for functional impairment: a comparison from patients with and without small bowel motility disorder. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf033
Vancouver
Collins K, González IA, Idrees MT, Gupta A, Wo JM, Saeed OAM. Loss of α-smooth muscle actin immunostaining is not a useful marker for functional impairment: a comparison from patients with and without small bowel motility disorder. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf033
BibTeX
@article{Collins2025,
author = {Collins, Katrina and González, Iván A and Idrees, Muhammad T and Gupta, Anita and Wo, John M and Saeed, Omer A M},
title = {Loss of α-smooth muscle actin immunostaining is not a useful marker for functional impairment: a comparison from patients with and without small bowel motility disorder},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf033}
}
EUVIMED